NCT05620420Completed
A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma
Source: ClinicalTrials.gov · Last updated 26 Nov 2024
Brief summary (registry, in English)
Multiple myeloma patients with normal ability of communication and understanding will be enrolled. DT, GAD-7, PHQ-15 and PSQI scales are designed to assess the mental health status of the patients. Demographic and disease data of patients will be collected as well. The main aim is to explore the factors affecting the mental health of myeloma patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 501 (actual)
- First submitted
- 10 Nov 2022
- Start date
- 8 Nov 2022
- Primary completion date
- 7 Nov 2023
- Lead sponsor
- RenJi Hospital
- Diseases
- Multiple myeloma
- NCT number
- NCT05620420
What you commit to
- Study type: Observational
- Participants enrolled: 501
- From 8 Nov 2022 to the primary completion date, 7 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Who has kinship with other enrolled patients.
- Life expectancy of\< 6 months.
Who the study is looking for
- Patients with symptomatic multiple myeloma were diagnosed according to the criteria of Chinese multiple myeloma diagnosis and treatment guidelines (revised in 2022).
- Age ≥18 years, with junior high school education or above. Patients have normal ability of communication and understanding.
- Informed consent has been signed.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Jiaotong University School of Medicine, Renji Hospital Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.